Aspen Biosciences launches Pipeline, the program management software platform specifically for drug discovery. The groundbreaking ‘Pipeline’ Platform is now available for therapeutics development teams

Aspen Biosciences, a leading provider of custom software, and integrations for drug discovery companies, is excited to announce the launch of Pipeline, the drug discovery program management software platform.

Case Strengthens for Cardiac Myosin Inhibitor in SEQUOIA-HCM

Secondary efficacy analyses of the pivotal SEQUOIA-HCM trial continued to favor aficamten, supporting a potential role for another cardiac myosin inhibitor in obstructive hypertrophic cardiomyopathy

October 1, 2024

Stem-Cell Mobilization Booster Wins FDA Approval for Multiple Myeloma

The FDA has approved the CXCR4 antagonist motixafortide (Aphexda) for use with filgrastim (Neupogen) to mobilize stem cells for autologous transplantation in multiple myeloma, BioLineRx

September 12, 2023

Devoted Health Secures $175M to Expand Medicare Advantage Plans for Seniors

Ed Park, CEO at Devoted Health What You Should Know: – Devoted Health, a leading provider of all-in-one healthcare for Medicare beneficiaries, has secured $175M

January 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.